# CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation

> **NCT04558333** · — · TERMINATED · sponsor: **University Hospital, Antwerp** · enrollment: 24 (actual)

## Conditions studied

- Lung Transplant Failure and Rejection
- Primary Graft Dysfunction

## Interventions

- **OTHER:** blood and exhaled breath specimens

## Key facts

- **NCT ID:** NCT04558333
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-28
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-02-28
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** lack of resources (personnel and budget)
- **Last updated:** 2024-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04558333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04558333, "CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04558333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*